Please Note:
This profile was automatically generated using 30 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 30 references found on the Internet. This information has not been verified. Learn more...
View all 30 references Web References
-
1. pharmacistelink.com
pharmacistelink.com/news/story - [Cached]Published on: 11/11/2007 Last Visited: 11/11/2007
"These results are especially significant for post-stroke diabetic patients because they are more likely to develop progressive kidney disease," said Dr. Vito Campese, chief of the division of nephrology/hypertension at the University of Southern California. -
2. www.pfizer.ca
www.pfizer.ca/english/newsroom - [Cached]Published on: 11/5/2007 Last Visited: 12/6/2007
"These results are especially significant for post-stroke diabetic patients because they are more likely to develop progressive kidney disease," said Dr. Vito Campese, chief of the division of nephrology/hypertension at the University of Southern California. -
3. NKF K/DOQI Guidelines
www.kidney.org/professionals/K - [Cached]Published on: 9/12/2007 Last Visited: 5/25/2008
Vito M. Campese, MD, is Professor of Medicine, Physiology and Biophysics at the Keck School of Medicine, University of Southern California in Los Angeles, where he is Chief of the Division of Nephrology and Hypertension Center.Dr. Campese received his M.D. from the University of Bari in Italy.In 1974 he came to the United States via the University of Southern California for a fellowship in hypertension and was subsequently promoted to full Professor of Medicine with tenure in 1985.His main research interests are neurogenic factors in renal hypertension and salt-sensitivity in hypertension.He is the author or co-author of more than 235 scientific publications.Dr. Campese has been active in many professional societies, including the National Kidney Foundation, the American Society of Nephrology, and the American Society of Hypertension.He is a member of the Leadership Committee of the Council for High Blood Pressure.He has served or is serving on the editorial board of several renal and hypertension journals.

